Literature DB >> 8989721

6-Hydroxymelatonin sulfate excretion in human puberty.

A Cavallo1, L M Dolan.   

Abstract

We investigated the relationship of urinary excretion rate of 6-hydroxymelatonin sulfate (SM), the main metabolite of melatonin, with pubertal development and determined the day to day variability of SM excretion. Healthy subjects 4-31 years old completed one or multiple timed overnight urine collections. SM excretion rate per body size was significantly higher in 99 prepubertal subjects (35.5 +/- 2.3 ng/h/kg and 0.97 +/- 0.06 microgram/hr/m2) than in 86 pubertal subjects (18.1 +/- 1.1 ng/hr/kg and 0.61 +/- 0.03 microgram/hr/m2) or in 29 adults (15.0 +/- 1.5 ng/hr/kg and 0.59 +/- 0.06 microgram/hr/m2); no significant difference was present in pubertal stages 2 to 5. Among the prepubertal children, SM excretion rate in mid childhood was significantly higher than in late childhood. The variability of SM and creatinine excretion examined in 52 children, adolescents and adults with three or four collections was defined as the mean of the 52 coefficients of variation for the multiple measures in each subject. The variability of total nocturnal SM (25.9 +/- 2.6%) was similar to that of total creatinine (21.7 +/- 2.3%) and neither was significantly correlated with the variability in start time or duration of urine collection. The results suggest that, relative to body size, melatonin secretion rate is higher in mid childhood, decreases during late childhood, and remains stable from pubertal stage 2 to adulthood. The decline in melatonin secretion rate occurs during the developmental phase of disinhibition of the gonadotropin releasing hormone pulse generator. Hence, we infer that melatonin may be a suppressive factor of puberty during childhood. The substantial individual variability observed for SM excretion calls for caution in using single urine collections in longitudinal studies or in studies of drug responses.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8989721     DOI: 10.1111/j.1600-079x.1996.tb00290.x

Source DB:  PubMed          Journal:  J Pineal Res        ISSN: 0742-3098            Impact factor:   13.007


  8 in total

1.  Human puberty: salivary melatonin profiles in constant conditions.

Authors:  Stephanie J Crowley; Christine Acebo; Mary A Carskadon
Journal:  Dev Psychobiol       Date:  2011-09-27       Impact factor: 3.038

Review 2.  Adverse Events Associated with Melatonin for the Treatment of Primary or Secondary Sleep Disorders: A Systematic Review.

Authors:  Frank M C Besag; Michael J Vasey; Kim S J Lao; Ian C K Wong
Journal:  CNS Drugs       Date:  2019-12       Impact factor: 5.749

3.  Sulfation of 6-hydroxymelatonin, N-acetylserotonin and 4-hydroxyramelteon by the human cytosolic sulfotransferases (SULTs).

Authors:  Lijun Luo; Chunyang Zhou; Katsuhisa Kurogi; Yoichi Sakakibara; Masahito Suiko; Ming-Cheh Liu
Journal:  Xenobiotica       Date:  2015-11-17       Impact factor: 1.908

4.  Dose finding of melatonin for chronic idiopathic childhood sleep onset insomnia: an RCT.

Authors:  Ingeborg M van Geijlswijk; Kristiaan B van der Heijden; A C G Egberts; Hubert P L M Korzilius; Marcel G Smits
Journal:  Psychopharmacology (Berl)       Date:  2010-07-29       Impact factor: 4.530

5.  The effects of sleep and light at night on melatonin in adolescents.

Authors:  Caleb Hersh; Julia Sisti; Vincent Richiutti; Eva Schernhammer
Journal:  Hormones (Athens)       Date:  2015 Jul-Sep       Impact factor: 2.885

6.  Melatonin combats molecular terrorism at the mitochondrial level.

Authors:  Russel J Reiter; Sergio D Paredes; Ahmet Korkmaz; Mei-Jie Jou; Dun-Xian Tan
Journal:  Interdiscip Toxicol       Date:  2008-09

7.  Measurement of melatonin in body fluids: standards, protocols and procedures.

Authors:  Eduardo Alves de Almeida; Paolo Di Mascio; Tatsuo Harumi; D Warren Spence; Adam Moscovitch; Rüdiger Hardeland; Daniel P Cardinali; Gregory M Brown; S R Pandi-Perumal
Journal:  Childs Nerv Syst       Date:  2010-11-21       Impact factor: 1.475

Review 8.  Circadian dysrhythmia-linked diabetes mellitus: Examining melatonin's roles in prophylaxis and management.

Authors:  Adejoke Y Onaolapo; Olakunle J Onaolapo
Journal:  World J Diabetes       Date:  2018-07-15
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.